Novartis reported $8.33B in Trade Debtors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alcon AG ALC:SW USD 1.96B 131M
Amgen AMGN:US USD 5.56B 237M
Artemis Alpha ATS:LN GBP 781K 1.73M
AstraZeneca AZN:LN USD 11.25B 1.19B
Bayer BAYN:GR EUR 13.74B 1.01B
Biogen BIIB:US USD 2.14B 152.2M
Fresenius FRE:GR EUR 7.01B 1.14B
Galapagos GLPG:NA EUR 66.55M 12.18M
Genmab GEN:DC DKK 6.05B 1.1B
Gilead Sciences GILD:US USD 4.78B 423M
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Hikma Pharmaceutical HIK:LN USD 841M 52M
Merck MRK:GR EUR 4.69B 108M
Novartis NOVN:VX USD 8.33B 346M
Novartis NVS:US USD 8.33B 346M
Orion ORNBV:FH EUR 230.4M 27.1M
Recordati REC:IM EUR 443.06M 2.42M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Roche Holding ROG:VX 11.92B 841M